Cargando…

First person – Sarah Elzinga

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sarah Elzinga is first author on ‘Sex differences in insulin resistance, but not peripheral...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077552/
http://dx.doi.org/10.1242/dmm.049033
_version_ 1783684900570791936
collection PubMed
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sarah Elzinga is first author on ‘Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model’, published in DMM. Sarah is a postdoc in the lab of Eva Feldman at the University of Michigan, Ann Arbor, MI, USA, investigating immune-mediated mechanisms that promote neurodegeneration in obesity, metabolic syndrome, prediabetes and type 2 diabetes.
format Online
Article
Text
id pubmed-8077552
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-80775522021-04-27 First person – Sarah Elzinga Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sarah Elzinga is first author on ‘Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model’, published in DMM. Sarah is a postdoc in the lab of Eva Feldman at the University of Michigan, Ann Arbor, MI, USA, investigating immune-mediated mechanisms that promote neurodegeneration in obesity, metabolic syndrome, prediabetes and type 2 diabetes. The Company of Biologists Ltd 2021-04-15 /pmc/articles/PMC8077552/ http://dx.doi.org/10.1242/dmm.049033 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle First Person
First person – Sarah Elzinga
title First person – Sarah Elzinga
title_full First person – Sarah Elzinga
title_fullStr First person – Sarah Elzinga
title_full_unstemmed First person – Sarah Elzinga
title_short First person – Sarah Elzinga
title_sort first person – sarah elzinga
topic First Person
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077552/
http://dx.doi.org/10.1242/dmm.049033